Research Site 702 — Naples, Florida

Research Site 702 is a clinical research site located in Naples, Florida, United States 34105.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site 702 has participated in 1 clinical trials.

Therapeutic areas: Relapsing Multiple Sclerosis.

Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 702?

Research Site 702 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 702 conducted?

Research Site 702 has 1 clinical trials on record. Their work covers Relapsing Multiple Sclerosis.

Is Research Site 702 accredited by Crixeo Health?

Research Site 702 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 702?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.